Loading...
Loading...
Transfer of healthy donor stool to restore gut microbiome diversity and function.
82/100
Various (emerging therapy)
Single procedure or series over weeks, effects may last months to years
10 phases
4 targeted
Transfer of healthy donor stool to restore gut microbiome diversity and function. FDA-approved for recurrent C. diff, experimental for other conditions. Can be done via colonoscopy, endoscopy, enema, or oral capsules.
FDA-approved specifically for recurrent C. diff after 2021. Highly effective for C. diff. Experimental but promising for UC, IBS. Autism studies mixed. DIY has risks. Screen donors extensively. Future of microbiome medicine.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.